Analysis of Risk Factors and Prognosis of Pediatric Patients After Operations for Congenital Heart Disease
Sponsor
National Taiwan University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06031831
Collaborator
(none)
999
1
31.6
31.6
Study Details
Study Description
Brief Summary
This hospital-based retrospective study reviewed patients who underwent surgery for CHD between 2017 and 2020 and analyzed the clinical features and outcomes associated with airway anomalies.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
999 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Analysis of Epidemiology, Risk Factors, and Prognosis of Pediatric Patients After Operations for Congenital Heart Disease
Actual Study Start Date
:
May 15, 2022
Actual Primary Completion Date
:
Dec 31, 2022
Anticipated Study Completion Date
:
Dec 31, 2024
Outcome Measures
Primary Outcome Measures
- surgical mortality [1 year]
hospital expired after operation
- intermediate survival [5 years]
expired during follow-up
Secondary Outcome Measures
- post-operative ICU stay [1 year]
The length of ICU stay after operation
- post-operative intubated days [1 year]
The length of intubated days after operation
Eligibility Criteria
Criteria
Ages Eligible for Study:
0 Days
to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- all pediatric patients (age <18 years) who underwent surgery for CHD at our hospital between January 1, 2017, and December 31, 2020.
Exclusion Criteria:
- with much missing clinical data
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Jenghung Wu | Taipei City 100 | Taiwan R. | Taiwan | 100229 |
Sponsors and Collaborators
- National Taiwan University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT06031831
Other Study ID Numbers:
- 202205043RINB
First Posted:
Sep 11, 2023
Last Update Posted:
Sep 11, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: